Global Fusion Biopsy Market By End Use (Diagnostic centers, Hospitals and Ambulatory care centers), By Route (Transperineal and Transrectal), By Region, Industry Analysis and Forecast, 2020 - 2026
The Global Fusion Biopsy Market size is expected to reach $912.5 Million by 2026, rising at a market growth of 11.5% CAGR during the forecast period. Fusion biopsy is considered as the most reliable method of detection of prostate and breast cancer. It is difficult to visualize the entire prostrate even in the biopsy so there are many developments being done in fusion biopsy system such as trans-rectal ultra-guided prostate biopsy. The current biopsy system has less image resolution and chances biopsy needle can penetrate the tumor-free areas and it can be given negative results.
The second most common type of cancer in men is Prostate cancer. Each year more than 160,000 Americans are diagnosed with prostate cancer. For diagnosis and detection of prostate cancer, the primary diagnostic test includes Digital Rectal Examination (DRE) and Prostate Specific Antigen (PSA) as they are more affordable and accessible. Though the PSA test is largely used for the detection of benign tumors that results in pointless invasive procedures and it also costs higher healthcare. Consequently, the rising demand for a more specific and sensitive screening method in prostate cancer is likely to boost the market growth for fusion biopsy.
The survival rate in the case of prostate cancer is more as compared to other types of cancer. But, the survival rate for prostate cancer has been less reported at the metastatic stage of cancer. To prevent prostate cancer from reaching up to a metastatic stage is highly needed, and for this purpose, either active surveillance or surgical intervention with other types of medication is required. There are many risks associated with surgical intervention such as erectile dysfunction, bleeding, urinary tract infection, and urinary incontinence. Thus, patients are usually seeking active surveillance and opting for regular biopsy, which in turn, is anticipated to drive the market growth of the MR/Ultrasound biopsy system.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Strategies deployed in Fusion Biopsy Market
Nov-2018: Focal Healthcare received both FDA 510(k) clearance and Health Canada approval for its Fusion Bx 2.0 prostate biopsy solution. The Fusion Bx 2.0 is the second generation of Focal Healthcare’s prostate fusion biopsy device.
Sep-2016: UC-Care and AXELLA announced the Navigo and SmartBx Systems, new cutting edge vision for prostate MRI fusion biopsy. Navigo fuses previously captured prostate MRI images with live TRUS (transrectal ultrasound) images while the ultrasound transducer is inserted during the biopsy.
May-2016: Philips' business Invivo partnered with SonaCare Medical to license Invivo's UroNav fusion software with its Sonablate planning system. The partnership enabled clinicians to use the UroNav device to annotate and biopsy targeted prostate tissue and localizes the tissue appropriate for ablation directly with its Sonablate software.
Mar-2016: Eigen collaborated with Hitachi Medical Systems Europe. Under this collaboration, Hitachi was aimed to distribute the Artemis, Eigen's robotic 3D targeted prostate biopsy device, through their subsidiaries' sales network in Europe. Additionally, both companies expanded the versatility of Eigen's Artemis and Hitachi Aloka's suite of advanced ultrasound units, including their newest and most compact ultrasound unit yet, the Noblus.
Mar-2016: Hitachi signed an agreement with MedCom GmbH to distribute the latter company's products through Hitachi's subsidiaries sales network in Europe. BiopSee is the MedCom's fusion imaging system for stereotactic, navigated, targeted prostate biopsy & therapy guidance. It is used in conjunction with Hitachi ultrasound systems. Hitachi is the sole distributor of the BiopSee products in this territory for Hitachi's installed base and when bundled with Hitachi's products.
Feb-2016: Focal Healthcare got 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its targeted prostate biopsy device, Fusion Bx. With the availability of Fusion Bx, clinicians can accurately take targeted biopsies directly from suspicious cancer regions within the prostate using MRI-ultrasound 'fusion' technology.
Scope of the Study
Market Segmentation:
By End Use
o Canada
o Mexico
o Rest of North America
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
o Japan
o India
o South Korea
o Singapore
o Australia
o Rest of Asia Pacific
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
The second most common type of cancer in men is Prostate cancer. Each year more than 160,000 Americans are diagnosed with prostate cancer. For diagnosis and detection of prostate cancer, the primary diagnostic test includes Digital Rectal Examination (DRE) and Prostate Specific Antigen (PSA) as they are more affordable and accessible. Though the PSA test is largely used for the detection of benign tumors that results in pointless invasive procedures and it also costs higher healthcare. Consequently, the rising demand for a more specific and sensitive screening method in prostate cancer is likely to boost the market growth for fusion biopsy.
The survival rate in the case of prostate cancer is more as compared to other types of cancer. But, the survival rate for prostate cancer has been less reported at the metastatic stage of cancer. To prevent prostate cancer from reaching up to a metastatic stage is highly needed, and for this purpose, either active surveillance or surgical intervention with other types of medication is required. There are many risks associated with surgical intervention such as erectile dysfunction, bleeding, urinary tract infection, and urinary incontinence. Thus, patients are usually seeking active surveillance and opting for regular biopsy, which in turn, is anticipated to drive the market growth of the MR/Ultrasound biopsy system.
Based on End Use, the market is segmented into Diagnostic centers, Hospitals and Ambulatory care centers. Based on Route, the market is segmented into Transperineal and Transrectal. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Hitachi, Ltd., Baxter International, Inc. (MedCom), Esaote SpA, Eigen, KOELIS, Inc., Focal Healthcare, Inc. and UC-Care Medical Systems Ltd.
Strategies deployed in Fusion Biopsy Market
Nov-2018: Focal Healthcare received both FDA 510(k) clearance and Health Canada approval for its Fusion Bx 2.0 prostate biopsy solution. The Fusion Bx 2.0 is the second generation of Focal Healthcare’s prostate fusion biopsy device.
Sep-2016: UC-Care and AXELLA announced the Navigo and SmartBx Systems, new cutting edge vision for prostate MRI fusion biopsy. Navigo fuses previously captured prostate MRI images with live TRUS (transrectal ultrasound) images while the ultrasound transducer is inserted during the biopsy.
May-2016: Philips' business Invivo partnered with SonaCare Medical to license Invivo's UroNav fusion software with its Sonablate planning system. The partnership enabled clinicians to use the UroNav device to annotate and biopsy targeted prostate tissue and localizes the tissue appropriate for ablation directly with its Sonablate software.
Mar-2016: Eigen collaborated with Hitachi Medical Systems Europe. Under this collaboration, Hitachi was aimed to distribute the Artemis, Eigen's robotic 3D targeted prostate biopsy device, through their subsidiaries' sales network in Europe. Additionally, both companies expanded the versatility of Eigen's Artemis and Hitachi Aloka's suite of advanced ultrasound units, including their newest and most compact ultrasound unit yet, the Noblus.
Mar-2016: Hitachi signed an agreement with MedCom GmbH to distribute the latter company's products through Hitachi's subsidiaries sales network in Europe. BiopSee is the MedCom's fusion imaging system for stereotactic, navigated, targeted prostate biopsy & therapy guidance. It is used in conjunction with Hitachi ultrasound systems. Hitachi is the sole distributor of the BiopSee products in this territory for Hitachi's installed base and when bundled with Hitachi's products.
Feb-2016: Focal Healthcare got 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its targeted prostate biopsy device, Fusion Bx. With the availability of Fusion Bx, clinicians can accurately take targeted biopsies directly from suspicious cancer regions within the prostate using MRI-ultrasound 'fusion' technology.
Scope of the Study
Market Segmentation:
By End Use
- Diagnostic centers
- Hospitals
- Ambulatory care centers
- Transperineal
- Transrectal
- North America
o Canada
o Mexico
o Rest of North America
- Europe
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
- Asia Pacific
o Japan
o India
o South Korea
o Singapore
o Australia
o Rest of Asia Pacific
- LAMEA
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
- Koninklijke Philips N.V.
- Hitachi, Ltd.
- Baxter International, Inc. (MedCom)
- Esaote SpA
- Eigen
- KOELIS, Inc.
- Focal Healthcare, Inc.
- UC-Care Medical Systems Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Fusion Biopsy Market, by End Use
1.4.2 Global Fusion Biopsy Market, by Route
1.4.3 Global Fusion Biopsy Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. GLOBAL FUSION BIOPSY MARKET BY END USE
4.1 Global Diagnostic centers Market by Region
4.2 Global Hospitals Market by Region
4.3 Global Ambulatory care centers Market by Region
CHAPTER 5. GLOBAL FUSION BIOPSY MARKET BY ROUTE
5.1 Global Transperineal Market by Region
5.2 Global Transrectal Market by Region
CHAPTER 6. GLOBAL FUSION BIOPSY MARKET BY REGION
6.1 North America Fusion Biopsy Market
6.1.1 North America Fusion Biopsy Market by End Uses
6.1.1.1 North America Diagnostic centers Market by Country
6.1.1.2 North America Hospitals Market by Country
6.1.1.3 North America Ambulatory care centers Market by Country
6.1.2 North America Fusion Biopsy Market by Route
6.1.2.1 North America Transperineal Market by Country
6.1.2.2 North America Transrectal Market by Country
6.1.3 North America Fusion Biopsy Market by Country
6.1.3.1 USA Fusion Biopsy Market
6.1.3.1.1 USA Fusion Biopsy Market by End Uses
6.1.3.1.2 USA Fusion Biopsy Market by Route
6.1.3.2 Canada Fusion Biopsy Market
6.1.3.2.1 Canada Fusion Biopsy Market by End Users
6.1.3.2.2 Canada Fusion Biopsy Market by Route
6.1.3.3 Mexico Fusion Biopsy Market
6.1.3.3.1 Mexico Fusion Biopsy Market by End Users
6.1.3.3.2 Mexico Fusion Biopsy Market by Route
6.1.3.4 Rest of North America Fusion Biopsy Market
6.1.3.4.1 Rest of North America Fusion Biopsy Market by End Users
6.1.3.4.2 Rest of North America Fusion Biopsy Market by Route
6.2 Europe Fusion Biopsy Market
6.2.1 Europe Fusion Biopsy Market by End Uses
6.2.1.1 Europe Diagnostic centers Market by Country
6.2.1.2 Europe Hospitals Market by Country
6.2.1.3 Europe Ambulatory care centers Market by Country
6.2.2 Europe Fusion Biopsy Market by Route
6.2.2.1 Europe Transperineal Market by Country
6.2.2.2 Europe Transrectal Market by Country
6.2.3 Europe Fusion Biopsy Market by Country
6.2.3.1 Germany Fusion Biopsy Market
6.2.3.1.1 Germany Fusion Biopsy Market by End Uses
6.2.3.1.2 Germany Fusion Biopsy Market by Route
6.2.3.2 UK Fusion Biopsy Market
6.2.3.2.1 UK Fusion Biopsy Market by End Uses
6.2.3.2.2 UK Fusion Biopsy Market by Route
6.2.3.3 France Fusion Biopsy Market
6.2.3.3.1 France Fusion Biopsy Market by End Uses
6.2.3.3.2 France Fusion Biopsy Market by Route
6.2.3.4 Russia Fusion Biopsy Market
6.2.3.4.1 Russia Fusion Biopsy Market by End Uses
6.2.3.4.2 Russia Fusion Biopsy Market by Route
6.2.3.5 Spain Fusion Biopsy Market
6.2.3.5.1 Spain Fusion Biopsy Market by End Uses
6.2.3.5.2 Spain Fusion Biopsy Market by Route
6.2.3.6 Italy Fusion Biopsy Market
6.2.3.6.1 Italy Fusion Biopsy Market by End Uses
6.2.3.6.2 Italy Fusion Biopsy Market by Route
6.2.3.7 Rest of Europe Fusion Biopsy Market
6.2.3.7.1 Rest of Europe Fusion Biopsy Market by End Uses
6.2.3.7.2 Rest of Europe Fusion Biopsy Market by Route
6.3 Asia Pacific Fusion Biopsy Market
6.3.1 Asia Pacific Fusion Biopsy Market by End Uses
6.3.1.1 Asia Pacific Diagnostic centers Market by Country
6.3.1.2 Asia Pacific Hospitals Market by Country
6.3.1.3 Asia Pacific Ambulatory care centers Market by Country
6.3.2 Asia Pacific Fusion Biopsy Market by Route
6.3.2.1 Asia Pacific Transperineal Market by Country
6.3.2.2 Asia Pacific Transrectal Market by Country
6.3.3 Asia Pacific Fusion Biopsy Market by Country
6.3.3.1 China Fusion Biopsy Market
6.3.3.1.1 China Fusion Biopsy Market by End Uses
6.3.3.1.2 China Fusion Biopsy Market by Route
6.3.3.2 India Fusion Biopsy Market
6.3.3.2.1 India Fusion Biopsy Market by End Uses
6.3.3.2.2 India Fusion Biopsy Market by Route
6.3.3.3 Japan Fusion Biopsy Market
6.3.3.3.1 Japan Fusion Biopsy Market by End Uses
6.3.3.3.2 Japan Fusion Biopsy Market by Route
6.3.3.4 Australia Fusion Biopsy Market
6.3.3.4.1 Australia Fusion Biopsy Market by End Uses
6.3.3.4.2 Australia Fusion Biopsy Market by Route
6.3.3.5 South Korea Fusion Biopsy Market
6.3.3.5.1 South Korea Fusion Biopsy Market by End Uses
6.3.3.5.2 South Korea Fusion Biopsy Market by Route
6.3.3.6 Singapore Fusion Biopsy Market
6.3.3.6.1 Singapore Fusion Biopsy Market by End Uses
6.3.3.6.2 Singapore Fusion Biopsy Market by Route
6.3.3.7 Rest of Asia Pacific Fusion Biopsy Market
6.3.3.7.1 Rest of Asia Pacific Fusion Biopsy Market by End Uses
6.3.3.7.2 Rest of Asia Pacific Fusion Biopsy Market by Route
6.4 LAMEA Fusion Biopsy Market
6.4.1 LAMEA Fusion Biopsy Market by End Uses
6.4.1.1 LAMEA Diagnostic centers Market by Country
6.4.1.2 LAMEA Hospitals Market by Country
6.4.1.3 LAMEA Ambulatory care centers Market by Country
6.4.2 LAMEA Fusion Biopsy Market by Route
6.4.2.1 LAMEA Transperineal Market by Country
6.4.2.2 LAMEA Transrectal Market by Country
6.4.3 LAMEA Fusion Biopsy Market by Country
6.4.3.1 Brazil Fusion Biopsy Market
6.4.3.1.1 Brazil Fusion Biopsy Market by End Uses
6.4.3.1.2 Brazil Fusion Biopsy Market by Route
6.4.3.2 Argentina Fusion Biopsy Market
6.4.3.2.1 Argentina Fusion Biopsy Market by End Uses
6.4.3.2.2 Argentina Fusion Biopsy Market by Route
6.4.3.3 UAE Fusion Biopsy Market
6.4.3.3.1 UAE Fusion Biopsy Market by End Uses
6.4.3.3.2 UAE Fusion Biopsy Market by Route
6.4.3.4 Saudi Arabia Fusion Biopsy Market
6.4.3.4.1 Saudi Arabia Fusion Biopsy Market by End Uses
6.4.3.4.2 Saudi Arabia Fusion Biopsy Market by Route
6.4.3.5 South Africa Fusion Biopsy Market
6.4.3.5.1 South Africa Fusion Biopsy Market by End Uses
6.4.3.5.2 South Africa Fusion Biopsy Market by Route
6.4.3.6 Nigeria Fusion Biopsy Market
6.4.3.6.1 Nigeria Fusion Biopsy Market by End Uses
6.4.3.6.2 Nigeria Fusion Biopsy Market by Route
6.4.3.7 Rest of LAMEA Fusion Biopsy Market
6.4.3.7.1 Rest of LAMEA Fusion Biopsy Market by End Uses
6.4.3.7.2 Rest of LAMEA Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Fusion Biopsy Market, by End Use
1.4.2 Global Fusion Biopsy Market, by Route
1.4.3 Global Fusion Biopsy Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. RECENT MARKET DEVELOPMENTS IN FUSION BIOPSY MARKET
CHAPTER 4. GLOBAL FUSION BIOPSY MARKET BY END USE
4.1 Global Diagnostic centers Market by Region
4.2 Global Hospitals Market by Region
4.3 Global Ambulatory care centers Market by Region
CHAPTER 5. GLOBAL FUSION BIOPSY MARKET BY ROUTE
5.1 Global Transperineal Market by Region
5.2 Global Transrectal Market by Region
CHAPTER 6. GLOBAL FUSION BIOPSY MARKET BY REGION
6.1 North America Fusion Biopsy Market
6.1.1 North America Fusion Biopsy Market by End Uses
6.1.1.1 North America Diagnostic centers Market by Country
6.1.1.2 North America Hospitals Market by Country
6.1.1.3 North America Ambulatory care centers Market by Country
6.1.2 North America Fusion Biopsy Market by Route
6.1.2.1 North America Transperineal Market by Country
6.1.2.2 North America Transrectal Market by Country
6.1.3 North America Fusion Biopsy Market by Country
6.1.3.1 USA Fusion Biopsy Market
6.1.3.1.1 USA Fusion Biopsy Market by End Uses
6.1.3.1.2 USA Fusion Biopsy Market by Route
6.1.3.2 Canada Fusion Biopsy Market
6.1.3.2.1 Canada Fusion Biopsy Market by End Users
6.1.3.2.2 Canada Fusion Biopsy Market by Route
6.1.3.3 Mexico Fusion Biopsy Market
6.1.3.3.1 Mexico Fusion Biopsy Market by End Users
6.1.3.3.2 Mexico Fusion Biopsy Market by Route
6.1.3.4 Rest of North America Fusion Biopsy Market
6.1.3.4.1 Rest of North America Fusion Biopsy Market by End Users
6.1.3.4.2 Rest of North America Fusion Biopsy Market by Route
6.2 Europe Fusion Biopsy Market
6.2.1 Europe Fusion Biopsy Market by End Uses
6.2.1.1 Europe Diagnostic centers Market by Country
6.2.1.2 Europe Hospitals Market by Country
6.2.1.3 Europe Ambulatory care centers Market by Country
6.2.2 Europe Fusion Biopsy Market by Route
6.2.2.1 Europe Transperineal Market by Country
6.2.2.2 Europe Transrectal Market by Country
6.2.3 Europe Fusion Biopsy Market by Country
6.2.3.1 Germany Fusion Biopsy Market
6.2.3.1.1 Germany Fusion Biopsy Market by End Uses
6.2.3.1.2 Germany Fusion Biopsy Market by Route
6.2.3.2 UK Fusion Biopsy Market
6.2.3.2.1 UK Fusion Biopsy Market by End Uses
6.2.3.2.2 UK Fusion Biopsy Market by Route
6.2.3.3 France Fusion Biopsy Market
6.2.3.3.1 France Fusion Biopsy Market by End Uses
6.2.3.3.2 France Fusion Biopsy Market by Route
6.2.3.4 Russia Fusion Biopsy Market
6.2.3.4.1 Russia Fusion Biopsy Market by End Uses
6.2.3.4.2 Russia Fusion Biopsy Market by Route
6.2.3.5 Spain Fusion Biopsy Market
6.2.3.5.1 Spain Fusion Biopsy Market by End Uses
6.2.3.5.2 Spain Fusion Biopsy Market by Route
6.2.3.6 Italy Fusion Biopsy Market
6.2.3.6.1 Italy Fusion Biopsy Market by End Uses
6.2.3.6.2 Italy Fusion Biopsy Market by Route
6.2.3.7 Rest of Europe Fusion Biopsy Market
6.2.3.7.1 Rest of Europe Fusion Biopsy Market by End Uses
6.2.3.7.2 Rest of Europe Fusion Biopsy Market by Route
6.3 Asia Pacific Fusion Biopsy Market
6.3.1 Asia Pacific Fusion Biopsy Market by End Uses
6.3.1.1 Asia Pacific Diagnostic centers Market by Country
6.3.1.2 Asia Pacific Hospitals Market by Country
6.3.1.3 Asia Pacific Ambulatory care centers Market by Country
6.3.2 Asia Pacific Fusion Biopsy Market by Route
6.3.2.1 Asia Pacific Transperineal Market by Country
6.3.2.2 Asia Pacific Transrectal Market by Country
6.3.3 Asia Pacific Fusion Biopsy Market by Country
6.3.3.1 China Fusion Biopsy Market
6.3.3.1.1 China Fusion Biopsy Market by End Uses
6.3.3.1.2 China Fusion Biopsy Market by Route
6.3.3.2 India Fusion Biopsy Market
6.3.3.2.1 India Fusion Biopsy Market by End Uses
6.3.3.2.2 India Fusion Biopsy Market by Route
6.3.3.3 Japan Fusion Biopsy Market
6.3.3.3.1 Japan Fusion Biopsy Market by End Uses
6.3.3.3.2 Japan Fusion Biopsy Market by Route
6.3.3.4 Australia Fusion Biopsy Market
6.3.3.4.1 Australia Fusion Biopsy Market by End Uses
6.3.3.4.2 Australia Fusion Biopsy Market by Route
6.3.3.5 South Korea Fusion Biopsy Market
6.3.3.5.1 South Korea Fusion Biopsy Market by End Uses
6.3.3.5.2 South Korea Fusion Biopsy Market by Route
6.3.3.6 Singapore Fusion Biopsy Market
6.3.3.6.1 Singapore Fusion Biopsy Market by End Uses
6.3.3.6.2 Singapore Fusion Biopsy Market by Route
6.3.3.7 Rest of Asia Pacific Fusion Biopsy Market
6.3.3.7.1 Rest of Asia Pacific Fusion Biopsy Market by End Uses
6.3.3.7.2 Rest of Asia Pacific Fusion Biopsy Market by Route
6.4 LAMEA Fusion Biopsy Market
6.4.1 LAMEA Fusion Biopsy Market by End Uses
6.4.1.1 LAMEA Diagnostic centers Market by Country
6.4.1.2 LAMEA Hospitals Market by Country
6.4.1.3 LAMEA Ambulatory care centers Market by Country
6.4.2 LAMEA Fusion Biopsy Market by Route
6.4.2.1 LAMEA Transperineal Market by Country
6.4.2.2 LAMEA Transrectal Market by Country
6.4.3 LAMEA Fusion Biopsy Market by Country
6.4.3.1 Brazil Fusion Biopsy Market
6.4.3.1.1 Brazil Fusion Biopsy Market by End Uses
6.4.3.1.2 Brazil Fusion Biopsy Market by Route
6.4.3.2 Argentina Fusion Biopsy Market
6.4.3.2.1 Argentina Fusion Biopsy Market by End Uses
6.4.3.2.2 Argentina Fusion Biopsy Market by Route
6.4.3.3 UAE Fusion Biopsy Market
6.4.3.3.1 UAE Fusion Biopsy Market by End Uses
6.4.3.3.2 UAE Fusion Biopsy Market by Route
6.4.3.4 Saudi Arabia Fusion Biopsy Market
6.4.3.4.1 Saudi Arabia Fusion Biopsy Market by End Uses
6.4.3.4.2 Saudi Arabia Fusion Biopsy Market by Route
6.4.3.5 South Africa Fusion Biopsy Market
6.4.3.5.1 South Africa Fusion Biopsy Market by End Uses
6.4.3.5.2 South Africa Fusion Biopsy Market by Route
6.4.3.6 Nigeria Fusion Biopsy Market
6.4.3.6.1 Nigeria Fusion Biopsy Market by End Uses
6.4.3.6.2 Nigeria Fusion Biopsy Market by Route
6.4.3.7 Rest of LAMEA Fusion Biopsy Market
6.4.3.7.1 Rest of LAMEA Fusion Biopsy Market by End Uses
6.4.3.7.2 Rest of LAMEA Fusion Biopsy Market by Route
CHAPTER 7. COMPANY PROFILES
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.2 Hitachi, Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Baxter International, Inc. (MedCom)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.4 Esaote SpA
7.4.1 Company Overview
7.5 Eigen
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 KOELIS, Inc.
7.6.1 Company Overview
7.7 Focal Healthcare, Inc.
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Approvals:
7.8 UC-Care Medical Systems Ltd.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
TABLE 1 GLOBAL FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 GLOBAL FUSION BIOPSY MARKET BY END USE, 2016 - 2019, USD MILLION
TABLE 4 GLOBAL FUSION BIOPSY MARKET BY END USE, 2020 - 2026, USD MILLION
TABLE 5 GLOBAL DIAGNOSTIC CENTERS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 6 GLOBAL DIAGNOSTIC CENTERS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 7 GLOBAL HOSPITALS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL HOSPITALS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL AMBULATORY CARE CENTERS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL AMBULATORY CARE CENTERS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL TRANSPERINEAL MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL TRANSPERINEAL MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL TRANSRECTAL MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL TRANSRECTAL MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL FUSION BIOPSY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL FUSION BIOPSY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 USA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 USA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 USA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 USA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 USA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 USA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 CANADA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 CANADA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 CANADA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 46 CANADA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 47 CANADA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 CANADA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 MEXICO FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 MEXICO FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 MEXICO FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 52 MEXICO FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 53 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 58 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 59 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 62 EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 63 EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 64 EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 65 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 66 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 67 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 68 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 69 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 70 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 71 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 72 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 73 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 74 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 75 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 76 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 77 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 78 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 79 GERMANY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 80 GERMANY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 81 GERMANY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 82 GERMANY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 83 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 84 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 85 UK FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 86 UK FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 87 UK FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 88 UK FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 89 UK FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 90 UK FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 91 FRANCE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 92 FRANCE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 93 FRANCE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 94 FRANCE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 95 FRANCE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 96 FRANCE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 97 RUSSIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 98 RUSSIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 99 RUSSIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 100 RUSSIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 101 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 102 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 103 SPAIN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 104 SPAIN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 105 SPAIN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 106 SPAIN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 107 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 108 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 109 ITALY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 110 ITALY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 111 ITALY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 112 ITALY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 113 ITALY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 114 ITALY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 115 REST OF EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 116 REST OF EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 117 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 118 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 119 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 120 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 121 ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 122 ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 123 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 124 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 125 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 126 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 127 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 128 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 129 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 130 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 131 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 132 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 133 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 134 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 135 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 136 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 137 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 138 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 139 CHINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 140 CHINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 141 CHINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 142 CHINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 143 CHINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 144 CHINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 145 INDIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 146 INDIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 147 INDIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 148 INDIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 149 INDIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 150 INDIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 151 JAPAN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 152 JAPAN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 153 JAPAN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 154 JAPAN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 155 JAPAN FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 156 JAPAN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 157 AUSTRALIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 158 AUSTRALIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 159 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 160 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 161 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 162 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 163 SOUTH KOREA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 164 SOUTH KOREA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 165 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 166 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 167 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 168 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 169 SINGAPORE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 170 SINGAPORE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 171 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 172 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 173 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 174 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 175 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 176 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 177 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 178 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 179 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 180 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 181 LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 182 LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 183 LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 184 LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 185 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 186 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 187 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 188 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 189 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 190 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 191 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 192 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 193 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 194 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 195 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 196 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 197 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 198 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 199 BRAZIL FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 200 BRAZIL FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 201 BRAZIL FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 202 BRAZIL FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 203 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 204 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 205 ARGENTINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 206 ARGENTINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 207 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 208 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 209 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 210 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 211 UAE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 212 UAE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 213 UAE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 214 UAE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 215 UAE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 216 UAE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 217 SAUDI ARABIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 218 SAUDI ARABIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 219 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 220 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 221 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 222 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 223 SOUTH AFRICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 224 SOUTH AFRICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 225 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 226 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 227 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 228 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 229 NIGERIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 230 NIGERIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 231 NIGERIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 232 NIGERIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 233 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 234 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 235 REST OF LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 236 REST OF LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 237 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 238 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 239 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 240 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 241 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 242 KEY INFORMATION – HITACHI, LTD.
TABLE 243 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 244 KEY INFORMATION – ESAOTE SPA
TABLE 245 KEY INFORMATION – EIGEN
TABLE 246 KEY INFORMATION – KOELIS, INC.
TABLE 247 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 248 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
TABLE 1 GLOBAL FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 2 GLOBAL FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 3 GLOBAL FUSION BIOPSY MARKET BY END USE, 2016 - 2019, USD MILLION
TABLE 4 GLOBAL FUSION BIOPSY MARKET BY END USE, 2020 - 2026, USD MILLION
TABLE 5 GLOBAL DIAGNOSTIC CENTERS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 6 GLOBAL DIAGNOSTIC CENTERS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 7 GLOBAL HOSPITALS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 8 GLOBAL HOSPITALS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 9 GLOBAL AMBULATORY CARE CENTERS MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 10 GLOBAL AMBULATORY CARE CENTERS MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 11 GLOBAL FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 12 GLOBAL FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 13 GLOBAL TRANSPERINEAL MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 14 GLOBAL TRANSPERINEAL MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 15 GLOBAL TRANSRECTAL MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 16 GLOBAL TRANSRECTAL MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 17 GLOBAL FUSION BIOPSY MARKET BY REGION, 2016 - 2019, USD MILLION
TABLE 18 GLOBAL FUSION BIOPSY MARKET BY REGION, 2020 - 2026, USD MILLION
TABLE 19 NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 20 NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 36 NORTH AMERICA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 37 USA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 38 USA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 39 USA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 40 USA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 41 USA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 42 USA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 43 CANADA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 44 CANADA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 45 CANADA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 46 CANADA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 47 CANADA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 48 CANADA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 49 MEXICO FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 50 MEXICO FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 51 MEXICO FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 52 MEXICO FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 53 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 54 MEXICO FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 55 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 56 REST OF NORTH AMERICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 57 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2016 - 2019, USD MILLION
TABLE 58 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY END USERS, 2020 - 2026, USD MILLION
TABLE 59 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 60 REST OF NORTH AMERICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 61 EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 62 EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 63 EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 64 EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 65 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 66 EUROPE DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 67 EUROPE HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 68 EUROPE HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 69 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 70 EUROPE AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 71 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 72 EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 73 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 74 EUROPE TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 75 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 76 EUROPE TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 77 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 78 EUROPE FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 79 GERMANY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 80 GERMANY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 81 GERMANY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 82 GERMANY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 83 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 84 GERMANY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 85 UK FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 86 UK FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 87 UK FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 88 UK FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 89 UK FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 90 UK FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 91 FRANCE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 92 FRANCE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 93 FRANCE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 94 FRANCE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 95 FRANCE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 96 FRANCE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 97 RUSSIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 98 RUSSIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 99 RUSSIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 100 RUSSIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 101 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 102 RUSSIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 103 SPAIN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 104 SPAIN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 105 SPAIN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 106 SPAIN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 107 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 108 SPAIN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 109 ITALY FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 110 ITALY FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 111 ITALY FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 112 ITALY FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 113 ITALY FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 114 ITALY FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 115 REST OF EUROPE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 116 REST OF EUROPE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 117 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 118 REST OF EUROPE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 119 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 120 REST OF EUROPE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 121 ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 122 ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 123 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 124 ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 125 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 126 ASIA PACIFIC DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 127 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 128 ASIA PACIFIC HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 129 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 130 ASIA PACIFIC AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 131 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 132 ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 133 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 134 ASIA PACIFIC TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 135 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 136 ASIA PACIFIC TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 137 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 138 ASIA PACIFIC FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 139 CHINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 140 CHINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 141 CHINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 142 CHINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 143 CHINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 144 CHINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 145 INDIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 146 INDIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 147 INDIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 148 INDIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 149 INDIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 150 INDIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 151 JAPAN FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 152 JAPAN FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 153 JAPAN FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 154 JAPAN FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 155 JAPAN FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 156 JAPAN FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 157 AUSTRALIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 158 AUSTRALIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 159 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 160 AUSTRALIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 161 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 162 AUSTRALIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 163 SOUTH KOREA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 164 SOUTH KOREA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 165 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 166 SOUTH KOREA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 167 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 168 SOUTH KOREA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 169 SINGAPORE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 170 SINGAPORE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 171 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 172 SINGAPORE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 173 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 174 SINGAPORE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 175 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 176 REST OF ASIA PACIFIC FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 177 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 178 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 179 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 180 REST OF ASIA PACIFIC FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 181 LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 182 LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 183 LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 184 LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 185 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 186 LAMEA DIAGNOSTIC CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 187 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 188 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 189 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 190 LAMEA AMBULATORY CARE CENTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 191 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 192 LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 193 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 194 LAMEA TRANSPERINEAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 195 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 196 LAMEA TRANSRECTAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 197 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 198 LAMEA FUSION BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 199 BRAZIL FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 200 BRAZIL FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 201 BRAZIL FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 202 BRAZIL FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 203 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 204 BRAZIL FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 205 ARGENTINA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 206 ARGENTINA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 207 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 208 ARGENTINA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 209 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 210 ARGENTINA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 211 UAE FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 212 UAE FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 213 UAE FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 214 UAE FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 215 UAE FUSION BIOPSY MARKET BY SOURCE, 2016 - 2019, USD MILLION
TABLE 216 UAE FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 217 SAUDI ARABIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 218 SAUDI ARABIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 219 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 220 SAUDI ARABIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 221 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 222 SAUDI ARABIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 223 SOUTH AFRICA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 224 SOUTH AFRICA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 225 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 226 SOUTH AFRICA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 227 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 228 SOUTH AFRICA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 229 NIGERIA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 230 NIGERIA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 231 NIGERIA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 232 NIGERIA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 233 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 234 NIGERIA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 235 REST OF LAMEA FUSION BIOPSY MARKET, 2016 - 2019, USD MILLION
TABLE 236 REST OF LAMEA FUSION BIOPSY MARKET, 2020 - 2026, USD MILLION
TABLE 237 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2016 - 2019, USD MILLION
TABLE 238 REST OF LAMEA FUSION BIOPSY MARKET BY END USES, 2020 - 2026, USD MILLION
TABLE 239 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2016 - 2019, USD MILLION
TABLE 240 REST OF LAMEA FUSION BIOPSY MARKET BY ROUTE, 2020 - 2026, USD MILLION
TABLE 241 KEY INFORMATION – KONINKLIJKE PHILIPS N.V.
TABLE 242 KEY INFORMATION – HITACHI, LTD.
TABLE 243 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 244 KEY INFORMATION – ESAOTE SPA
TABLE 245 KEY INFORMATION – EIGEN
TABLE 246 KEY INFORMATION – KOELIS, INC.
TABLE 247 KEY INFORMATION – FOCAL HEALTHCARE, INC.
TABLE 248 KEY INFORMATION – UC-CARE MEDICAL SYSTEMS LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
